Focus Stocks
Trading Idea: - Is Oracle close to Resistance?
Published on Tuesday, 01 January 2013 07:28 Written by TradersHuddle Wire
New York, January 1st (TradersHuddle.com) - Shares of Oracle Corporation (NASDAQ:ORCL) are trading very close to calculated resistance at $34.35. The stock ended the trading session at just $33.02, which is near levels that make it difficult to buy or start a position.
Oracle Corporation (NASDAQ:ORCL) supplies software for enterprise information management. The Company offers databases and relational servers, application development, and enterprise business applications.
Oracle's stock range is defined by its calculated support defined at $29.52 and by the resistance level at $34.35; the stock is clearly over-extended from support, making it harder for participants to establish fresh longs.
Traders don't have a clear entry point for Oracle. However, as the stock pulls back towards $29.52 it will definitely provide a reference point to establish a trade. On the other hand, if the stock breaks above its resistance level at $34.35 then traders will get an opportunity to enter the stock as it moves to a higher range.
Related Articles
- Trading Idea: Momentum Building in Oracle
- Is Oracle Setting up for a Break Out?
- Oracle Is Dipping Below Support
- Oracle Is Close to Important Technical Levels
- The Range Is Tightening in Oracle
- The Range Is Tightening in Oracle
- Oracle Is Near Important Moving Averages
- Approaching Resistance: Oracle
- Above Resistance: Oracle
- Trading Idea: Is Oracle Breaking Out?
Related Partner Headlines
- Oracle Corporation Stock Buy Recommendation Reiterated (ORCL) - TheStreet.com
- Oracle Corporation (ORCL): Today's Featured Computer Software & Services Winner - TheStreet.com
- Oracle Makes Strategic Minority Investment in Engine Yard - Benzinga
- Oracle Corporation (ORCL): Today's Featured Computer Software & Services Laggard - TheStreet.com
- Oracle Corporation Stock Buy Recommendation Reiterated (ORCL) - TheStreet.com
- Oracle Corporation (ORCL): Today's Featured Computer Software & Services Winner - TheStreet.com
- Oracle Corporation Stock Buy Recommendation Reiterated (ORCL) - TheStreet.com
- Oracle Corporation (ORCL): Today's Featured Computer Software & Services Winner - TheStreet.com
- Oracle Corporation Stock Buy Recommendation Reiterated (ORCL) - TheStreet.com
- Oracle Corporation (ORCL): Today's Featured Computer Software & Services Laggard - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,293.50 Trade time:10:13AM EDT Value change:▼24.73 (-0.16%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,649.58 Trade time:10:13AM EDT Value change:▼2.23 (-0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,481.44 Trade time:10:13AM EDT Value change:▼0.74 (-0.02%)In The Wires
-
Monsanto Company Releases 2012 Sustainability Report -
Marquest Asset Management Inc. Announces Distribution for Marquest Canadian Equity Income Fund -
CSX Corporation Announces Earnings Release and Second-Quarter Earnings Call -
Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System -
Two "Newest" Value Line Funds to Reach 20-Year Anniversary Milestone in 2013 -
REIT Exchange Fund Revises Terms of Exchange Offers for Non-Traded REITs -
Critical Alerts For Chevron, Coca Cola, JC Penney, Union Pacific, and US Bancorp Released By InvestorsObserver -
Critical Alerts For Hormel Foods, Steelcase, Exact Sciences, GenCorp, and Infinity Pharmaceuticals Released By InvestorsObserver








